As of Jul 27
| -0.01 / -0.11%|
The 8 analysts offering 12-month price forecasts for Infinity Pharmaceuticals Inc have a median target of 18.00, with a high estimate of 24.00 and a low estimate of 11.00. The median estimate represents a +107.13% increase from the last price of 8.69.
The current consensus among 9 polled investment analysts is to Buy stock in Infinity Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.